Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF38 intronic transcript 1 (ARHGEF38-IT1)
- Target
- ARHGEF38-IT1
- Molecular classification
- Long non-coding RNA (lncRNA), Non-protein-coding RNA
01
Overview
ARHGEF38 intronic transcript 1 (ARHGEF38-IT1) is a human RNA gene classified as a long non-coding RNA (lncRNA). It is located within the intronic region of the ARHGEF38 gene but does not encode a protein. The biological role of ARHGEF38-IT1 remains uncharacterized, reflecting the broader uncertainty about many lncRNAs, which are known to participate in diverse gene regulatory mechanisms but whose individual effects often remain undefined. ARHGEF38-IT1 is not currently considered a therapeutic target, nor are there reported disease associations, interacting drugs, or biomarker uses. It represents a member of the large and expanding family of non-coding RNAs that contribute to the regulatory complexity of the human genome[1][3][6].
- Other names
- ARHGEF38 intronic transcript 1 (non-protein coding)ARHGEF38-IT1
02
Mechanism of action
Not established; typical for lncRNAs is regulation of gene expression through interactions with DNA, RNA, and proteins, often affecting transcription, mRNA splicing, or chromatin architecture
03
Biological functions
The specific functions of ARHGEF38-IT1 are not described in the literature.lncRNAs in general are involved in gene regulationlncRNAs in general are involved in chromatin remodelinglncRNAs in general are involved in epigenetic control
04
Disease associations
There is no published evidence linking ARHGEF38-IT1 specifically to particular diseases.lncRNAs are often implicated in cancerlncRNAs are often implicated in neurodegenerative diseaselncRNAs are often implicated in other disorders via dysregulated gene expression
Beyond the preview
Go deeper on ARHGEF38 intronic transcript 1 (ARHGEF38-IT1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARHGEF38 intronic transcript 1 (ARHGEF38-IT1).